Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Clin Transl Oncol

Search In Journal Title:

Abbravation: Clinical and Translational Oncology

Search In Journal Abbravation:

Publisher

Springer Milan

Search In Publisher:

DOI

10.1016/0379-6787(86)90105-5

Search In DOI:

ISSN

1699-3055

Search In ISSN:
Search In Title Of Papers:

Multiple bone lesions resembling a metastatic orig

Authors: M José MolinaGarrido Antonia Mora Encarna Andrada Carmen GuillénPonce Víctor Cánovas M GuiradoRisueño Elisa Pastor M Ángeles Molina M Jesús Molina Alberto Martín Hidalgo Alfredo Carrato
Publish Date: 2008/10/05
Volume: 10, Issue: 4, Pages: 241-245
PDF Link

Abstract

Lytic and blastic lesions have been associated to malignant tumours such as solid cancer breast cancer renal cancer prostate cancer malignant melanoma or thyroid tumours Although a mixed pattern with lytic and blastic lesions is due to metastatic tumour this is not the only possible origin The following case shows a systematic This case report shows the number of tests that were made in order to discover the origin of osteolytic and osteoblastic lesions and it is notable that there is not an occult neoplasia on every occasion

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study
  2. The expression and function of Frizzled-7 in human renal cell carcinoma
  3. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma
  4. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
  5. Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)
  6. Dose–volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve
  7. Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases
  8. Breast metastases from a floor of the mouth carcinoma
  9. Clinical implications of KIT and PDGFRA genotyping in GIST
  10. Therapeutic vaccines for non-Hodgkin B-cell lymphoma
  11. Tissue fatty acid composition and secretory phospholipase-A2 activity in oral squamous cell carcinoma
  12. Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
  13. Gastrointestinal stromal tumours at present: an approach to burning questions
  14. Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on brachytherapy in Breast Cancer
  15. Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
  16. Selection of extreme phenotypes: the role of clinical observation in translational research
  17. VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells
  18. The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets
  19. GAL3ST2 from mammary gland epithelial cells affects differentiation of 3T3-L1 preadipocytes
  20. Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma
  21. Retroperitoneal lymph node dissection: an update in testicular malignancies
  22. Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma
  23. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients
  24. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients
  25. Pralatrexate, a new hope for aggressive T-cell lymphomas?
Search Result: